F. Travert

3.1k total citations · 1 hit paper
20 papers, 1.7k citations indexed

About

F. Travert is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, F. Travert has authored 20 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Endocrinology, Diabetes and Metabolism, 7 papers in Cardiology and Cardiovascular Medicine and 5 papers in Surgery. Recurrent topics in F. Travert's work include Diabetes Treatment and Management (7 papers), Birth, Development, and Health (4 papers) and Diabetes Management and Research (4 papers). F. Travert is often cited by papers focused on Diabetes Treatment and Management (7 papers), Birth, Development, and Health (4 papers) and Diabetes Management and Research (4 papers). F. Travert collaborates with scholars based in France, United States and Canada. F. Travert's co-authors include John Chalmers, Anushka Patel, Bruce Neal, Mark Woodward, Toshiharu Ninomiya, Rury R. Holman, Hertzel C. Gerstein, Fiona Turnbull, Thomas Moritz and William C. Duckworth and has published in prestigious journals such as PLoS ONE, The Journal of Clinical Endocrinology & Metabolism and Diabetes Care.

In The Last Decade

F. Travert

19 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Intensive glucose control and macrovascular outcomes in type 2 diabetes

2009 829 citations Fiona Turnbull, Carlos Abraira et al. Diabetologia profile →

Peers

Countries citing papers authored by F. Travert

Since Specialization

Citations

This map shows the geographic impact of F. Travert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Travert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Travert more than expected).

Fields of papers citing papers by F. Travert

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Travert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Travert. The network helps show where F. Travert may publish in the future.

Co-authorship network of co-authors of F. Travert

This figure shows the co-authorship network connecting the top 25 collaborators of F. Travert. A scholar is included among the top collaborators of F. Travert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Travert. F. Travert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Validation of the Body Scan®, a new device to detect small fiber neuropathy by assessment of the sudomotor function: agreement with the Sudoscan® 2023 ·Frontiers in Neurology ·Jean‐Pierre Riveline, Roberto Mallone, (unknown), (unknown), (unknown), (unknown), F. Travert, (unknown), Jean‐Baptiste Julla, Tiphaine Vidal-Trécan, Louis Potier, Jean–François Gautier, Étienne Larger, Jean‐Pascal Lefaucheur	3
2	Increased Risk of Severe Hypoglycemic Events Before and After Cardiovascular Outcomes in TECOS Suggests an At-Risk Type 2 Diabetes Frail Patient Phenotype 2018 ·Diabetes Care ·Eberhard Standl, Susanna R. Stevens, Paul W. Armstrong, John B. Buse, Juliana C.N. Chan, Jennifer B. Green, John M. Lachin, André Scheen, F. Travert, Frans Van de Werf, Eric D. Peterson, Rury R. Holman	49
3	Développement des biosimilaires de l’insuline : exemple de l’insuline glargine LY2963016 2018 ·La Presse Médicale ·Jean‐Jacques Altman, Nicolas Chevalier, Brigitte Delemer, F. Travert, Imane Benabbad	0
4	Randomized, double‐blind clinical trial comparing basal insulin peglispro and insulin glargine, in combination with prandial insulin lispro, in patients with type 1 diabetes: IMAGINE 3 2016 ·Diabetes Obesity and Metabolism ·Richard M. Bergenstal, Helen Lunt, Edward Franek, F. Travert, (unknown), Yongming Qu, Caryl J. Antalis, Mark L. Hartman, Myriam Rosilio, Scott J. Jacober, Edward J. Bastyr, (unknown)	40
5	Outpatient measurement of arterial stiffness in patients with type 2 diabetes and obesity 2016 ·Journal of Diabetes ·Kamel Mohammedi, (unknown), Louis Potier, (unknown), (unknown), (unknown), F. Travert, Boris Hansel, Gilberto Velho, Ronan Roussel, Magid Hallab, Michel Marre	6
6	Kidney Dysfunction in Adult Offspring Exposed In Utero to Type 1 Diabetes Is Associated with Alterations in Genome-Wide DNA Methylation 2015 ·PLoS ONE ·Jean–François Gautier, Raphaël Porcher, Charbel Abi Khalil, Naïma Bellili-Muñoz, (unknown), F. Travert, Siméon-Pierre Choukem, Jean‐Pierre Riveline, Samy Hadjadj, Étienne Larger, Philippe Boudou, B. Blondeau, Ronan Roussel, Pascal Ferré, Éric Ravussin, François Rouzet, Michel Marre	20
7	Use of Fibrates Monotherapy in People with Diabetes and High Cardiovascular Risk in Primary Care: A French Nationwide Cohort Study Based on National Administrative Databases 2015 ·PLoS ONE ·Ronan Roussel, C. Chaignot, Alain Weill, F. Travert, Boris Hansel, Michel Marre, P. Ricordeau, François Alla, H. Allemand	11
8	Impact of morbid obesity on the kidney function of patients with type 2 diabetes 2015 ·Diabetes Research and Clinical Practice ·(unknown), Kamel Mohammedi, François Rouzet, (unknown), (unknown), F. Travert, Gilberto Velho, Ronan Roussel, Dominique Le Guludec, Michel Marre, Boris Hansel	10
9	Association of HbA1c levels with vascular complications and death in patients with type 2 diabetes: evidence of glycaemic thresholds 2011 ·Diabetologia ·(unknown), Sophia Zoungas, John Chalmers, Toshiharu Ninomiya, Qi Li, M. E. Cooper, Stephen Colagiuri, Gregory Fulcher, Bastiaan E. de Galan, Stephen Harrap, Pavel Hamet, Simon Heller, Stephen MacMahon, Michel Marre, Neil R Poulter, F. Travert, Anushka Patel, Bruce Neal, Mark Woodward	265
10	Intensifying glycaemic control with insulin reduces adiponectin and its HMW isoform moderately in type 2, but not in type 1, diabetes 2011 ·Diabetes & Metabolism ·Charbel Abi Khalil, Kamel Mohammedi, R. Aubert, F. Travert, (unknown), Ronan Roussel, Frédéric Fumeron, Michel Marre	5
11	Contemporary model for cardiovascular risk prediction in people with type 2 diabetes 2011 ·European Journal of Cardiovascular Prevention & Rehabilitation ·André Pascal Kengne, Anushka Patel, Michel Marre, F. Travert, Michel Lièvre, Sophia Zoungas, John Chalmers, Stephen Colagiuri, Diederick E. Grobbee, Pavel Hamet, Simon Heller, Bruce Neal, Mark Woodward	118
12	Associations of the -344 T>C and the 3097 G>A Polymorphisms of CYP11B2 Gene With Hypertension, Type 2 Diabetes, and Metabolic Syndrome in a French Population 2010 ·American Journal of Hypertension ·N. Bellili, L. Foucan, Frédéric Fumeron, Kamel Mohammedi, F. Travert, Ronan Roussel, Beverley Balkau, Jean Tichet, Michel Marre, (unknown)	20
13	Association of common variants in NPPA and NPPB with blood pressure does not translate into kidney damage in a general population study 2010 ·Journal of Hypertension ·(unknown), Ronan Roussel, Samy Hadjadj, Frédéric Fumeron, Roberte Aubert, (unknown), Gilberto Velho, Kamel Mohammedi, F. Travert, Jean Tichet, François Alhenc‐Gelas, Beverley Balkau, Michel Marre	4
14	Fetal Exposure to Maternal Type 1 Diabetes Is Associated With Renal Dysfunction at Adult Age 2010 ·Diabetes ·Charbel Abi Khalil, F. Travert, S. Fetita, François Rouzet, Raphaël Porcher, Jean‐Pierre Riveline, Samy Hadjadj, Étienne Larger, Ronan Roussel, Patrick Vexiau, Dominique Le Guludec, Jean–François Gautier, Michel Marre	36
15	Association of ADIPOQ genetic variants and plasma adiponectin isoforms with the risk of incident renal events in type 2 diabetes 2010 ·Nephrology Dialysis Transplantation ·Riphed Jaziri, Roberte Aubert, Ronan Roussel, (unknown), (unknown), N. Bellili, (unknown), Pierre‐Jean Saulnier, F. Travert, Samy Hadjadj, Michel Marre, Frédéric Fumeron, (unknown)	32
16	Hyperadiponectinemia Is Independent of Kidney Function, Diabetes Duration, and Control in Type 1 Diabetic Patients without Microangiopathy 2010 ·The Journal of Clinical Endocrinology & Metabolism ·Charbel Abi Khalil, Kamel Mohammedi, Roberte Aubert, (unknown), F. Travert, Samy Hadjadj, Frédéric Fumeron, Ronan Roussel, Michel Marre	4
17	Cognitive function and risks of cardiovascular disease and hypoglycaemia in patients with type 2 diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial 2009 ·Diabetologia ·(unknown), Bastiaan E. de Galan, Sophia Zoungas, John Chalmers, Craig S. Anderson, Carole Dufouil, Avinesh Pillai, M. E. Cooper, Diederick E. Grobbee, Maree L. Hackett, Pavel Hamet, Simon Heller, Lisheng Liu, Stephen MacMahon, Giuseppe Mancia, Bruce Neal, Changyu Pan, Anushka Patel, Neil R Poulter, F. Travert, Mark Woodward	160
18	Intensive glucose control and macrovascular outcomes in type 2 diabetes breakdown → 2009 ·Diabetologia ·Fiona Turnbull, Carlos Abraira, Robert J. Anderson, Robert P. Byington, John Chalmers, William C. Duckworth, Greg Evans, Hertzel C. Gerstein, Rury R. Holman, Thomas Moritz, Bruce Neal, Toshiharu Ninomiya, Anushka Patel, Sanjoy K. Paul, F. Travert, Mark Woodward	829
19	Relationships between common polymorphisms of adenosine triphosphate–binding cassette transporter A1 and high-density lipoprotein cholesterol and coronary heart disease in a population with type 2 diabetes mellitus 2008 ·Metabolism ·(unknown), Franck Péan, (unknown), (unknown), N. Bellili, F. Travert, Kamel Mohammedi, Ronan Roussel, Michel Marre, Frédéric Fumeron	38
20	Prognostic Value of the Insertion/Deletion Polymorphism of the ACE Gene in Type 2 Diabetic Subjects 2008 ·Diabetes Care ·Samy Hadjadj, Frédéric Fumeron, Ronan Roussel, Pierre‐Jean Saulnier, Yves Gallois, (unknown), F. Travert, Charbel Abi Khalil, (unknown), François Alhenc‐Gelas, Michel Lièvre, Michel Marre, (unknown)	51

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact